CopyMark Law Group
4.9/5
Drawing for HEPASTEM

USPTO serial 79270478

HEPASTEM

Reviewed by CopyMark Law Group

Reg. 6160743Status 700Renewal
Filing date
Status date
Registration date
Sep 29, 2020
Examiner
CIANCI, RYAN MICHAEL
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with HEPASTEM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*

Plus Government fees of $1,275

Trademark Monitoring(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Goods and services

ClassDescriptionStatusFirst use
005Cells originating from the liver, for medical, clinical or veterinary use, in particular liver stem cells or progenitor cells; pharmaceutical preparations for the treatment of liver diseases that require cell therapy medicinal productsACTIVE—
042Scientific and biotechnological medical research for the pharmaceutical and health care industry relating to development of new medicinal products for cell therapy; scientific and biotechnological medical research for the pharmaceutical and healthcare industry relating to the new product design, validation in the form of quality control, and development of application methods for using cells, in particular, liver stem cells and progenitor cells; development of methods for storage and transport of cells, in particular, liver stem cells and progenitor cellsACTIVE—
044Biomedical services for diagnosing and treating liver disease in relation to the testing of biological samples to determine the presence and activity of liver cells, in particular, liver stem cells and progenitor cells; medical and veterinary services for the isolation, analysis, processing, and administration of cells originating from the liver and in particular, liver stem cells and progenitor cells for diagnosing and treating liver diseaseACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 29, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jun 3, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Mar 12, 2023ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jun 26, 2021CHLDCHANGE OF OWNER RECEIVED FROM IB—
Feb 13, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 21, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 21, 2021FIMPFINAL DISPOSITION PROCESSED—
Dec 29, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 29, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 14, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 14, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 25, 2020NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 24, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 10, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 10, 2020XAECEXAMINER'S AMENDMENT ENTERED—
Jun 10, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 10, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 10, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
May 27, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 27, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 27, 2020ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
May 27, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 27, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 27, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Feb 8, 2020RFNTREFUSAL PROCESSED BY IB—
Jan 19, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 18, 2020RFRRREFUSAL PROCESSED BY MPU—
Dec 19, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 18, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 6, 2019DOCKASSIGNED TO EXAMINER—
Nov 5, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 30, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 24, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance